Navigation Links
Bradmer provides clinical trial update and announces evaluation of strategic alternatives
Date:2/17/2009

are evaluating strategic options related to the Bradmer assets and resources. While the cash on hand is not enough to finish the clinical trial, it is substantial enough to warrant careful consideration of proper deployment. It is envisioned that this strategic evaluation process will be reviewed by the Directors in March and recommendations will be forthcoming.

About Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most common and most advanced form of brain cancer with approximately 30,000 new cases diagnosed each year in the world's seven largest healthcare markets. Unlike many other solid tumors, GBM tumors do not metastasize, but cause symptoms and often death through invasion of nearby tissues and impairment of brain function. The current standard of care, consisting of surgery, radiation and adjuvant chemotherapy (temozolomide), extended average overall patient survival from 53 to 64 weeks.

About Neuradiab

Neuradiab is a monoclonal antibody, conjugated to radioactive iodine, used to treat glioblastoma multiforme (GBM), the most common and most advanced form of brain cancer. Neuradiab delivers tumor-killing radiation specifically to residual brain tumor cells after surgery, with minimal impact on normal brain tissue. During the course of development at Duke University, over US$60 million in research grants and related support has produced a series of Phase I and Phase II clinical trials on Neuradiab and other closely related technologies. Approximately 200 brain cancer patients, including over 160 with GBM, have been treated with the Neuradiab therapy regimen, and survival benefits have significantly exceeded historical controls in each completed trial. Neuradiab has been formerly referred to in literature as 131-I anti-tenascin monoclonal antibody 81c6.

GBM tumors typically have infiltrating edges that are very difficult to completely remove with surgery. The Ne
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
2. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
3. Bradmer announces 2008 third quarter operational and financial results
4. Bradmer to present at Rodman & Renshaw Healthcare Conference
5. Bradmer receives FDA approval to proceed with Phase III clinical trial
6. Bradmer announces 2008 first quarter operational and financial results
7. Bradmer announces new additions to management team
8. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
9. Notice of Bradmer Pharmaceuticals Conference Call
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... August 01, 2014 The "Antimicrobial ... such as Zinc Oxide, Titanium Dioxide, and Zinc ... & Construction, Food & Beverages, Textiles, and others), ... - Global Trends and Forecasts to 2018" analyzes ... drivers, opportunities, and trends in the diverse geographical ...
(Date:8/1/2014)... parents worry about their children choking on small objects or ... Such was the case for 15-month-old Landon Jones who started ... "At the time, Landon had a cold so it ... illness or choking," recalled his mother, Ula Jones. But, ... his windpipe and had to be removed via surgery. Landon ...
(Date:8/1/2014)... 01, 2014 For years, proponents have ... recent study conducted by the Ohio State ... far behind in terms of their health and development, ... what’s best for their baby. So does this new ... Dr. Steven Shapiro , chair of Pediatrics at Abington ...
(Date:8/1/2014)... (BRONX, NY) Scientists at Albert Einstein ... that bacteria that aid in digestion help keep the ... journal Immunity , could yield new therapies for ... other disorders. , The research involved the intestinal microbiome, ... these microorganisms in promoting or preventing disease is a ...
(Date:8/1/2014)... today’s age, traditional learning methods are futile in helping ... need to be revamped, so that the necessary subject ... age of the internet, online learning resources act as ... systems help in the planning, implementation, and assessment of ... proving to be very useful and this trend is ...
Breaking Medicine News(10 mins):Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Food Is a Common Choking Hazard for Kids, Doctor Says 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:'Normal' bacteria vital for keeping intestinal lining intact 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 4
... France's best-loved cheeses is in question after the two biggest ... untreated "raw" milk -- stopped production, citing health risks ... Lactalis and the Isigny Cooperative -- who together supplied 90 ... northwest region of Normandy -- have switched to using treated ...
... billion dollars) over the next eight years to the global ... to be published Thursday. ,Heidemarie Wieczorek-Zeul told ... to send a message to other member states during the ... Heiligendamm. ,"My appeal goes out to the other ...
... Hong Kong teenagers vibrates to the latest dance hit as a ... ,"Scream louder if you want more," a DJ shouts ... low-cut jeans throws his female partner onto his lap in a ... typical Friday night, but while many of the clubbers hail from ...
... Finnish Research study has found that exposure even a small ... serious and harmful impact on the cardiovascular system of a ... smoke can harm the childs arteries. ,Instead of relying ... the Finnish researchers used high-resolution ultrasound to check brachial artery ...
... old resident in New York, drank Boost Plus, a vitamin enriched ... ,When he woke up the next day, he had ... for medical advice and for treatment of the condition called severe ... is persistent, painful erection of the penis. Recurrent or severe episodes ...
... that the prison population in England and Wales reached a ... there were fewer than 300 cells available for new inmates. ... to house prisoners in some areas of the country. ... the BMAs Civil and Public Services Committee said: ...
Cached Medicine News:Health News:Fate of France's Cheeses in Doubt as Producers Cite Health Risks 2Health News:Fate of France's Cheeses in Doubt as Producers Cite Health Risks 3Health News:Drugs Lure Hong Kong Youth Across China Border 2Health News:Drugs Lure Hong Kong Youth Across China Border 3Health News:Prison Healthcare Under Strain as Overcrowding Crisis Worsens, Warns BMA 2
(Date:7/31/2014)... 2014  Cepheid (NASDAQ: CPHD ) today announced ... and invited investors to participate via webcast. ... York, NY Wednesday, August 13, 2014 at 9.10 ... New York, NY Thursday, September 4, ... Live Webcasts To access the live webcasts for these events, ...
(Date:7/31/2014)... VIEW, Calif. , July 31, 2014 /PRNewswire/ ... today provided an update on its pipeline and ... 2014, Alexza expects to initiate a Phase 2a ... is being developed for the management of patients ... two new Staccato -based product candidates for ...
(Date:7/31/2014)... July 31, 2014  UBM Medica US announces that ... community for oncologists, presents exclusive slide shows dealing with ... to quality cancer care. Cancer Network, ... , offers news, blogs, and podcasts about the latest ... cancer care: , End-of-life care is challenging ...
Breaking Medicine Technology:Cepheid to Webcast Upcoming Financial Presentations 2Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3
... TEL AVIV, Israel, December 20, 2011 During ... Board of Governors of the Israel-U.S. Binational Industrial Research ... for nine new projects between Israeli and American companies. In ... private sector funding, boosting the total value of all projects ...
...  The National Urban League (NUL) and the League of United ... to resume negotiations and come to an agreement with Walgreens ... millions of Americans, especially in diverse and underserved communities, stand ... In an open letter to Express Scripts, ...
Cached Medicine Technology:BIRD - Israel-US Binational Industrial R&D Foundation to Invest $8.1 Million in Nine new Projects 2BIRD - Israel-US Binational Industrial R&D Foundation to Invest $8.1 Million in Nine new Projects 3The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 2The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 3
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
Intended for the quantitative determination of iron in serum. Reaction: Endpoint. Wavelength: 595 nm. Linearity: 500 g/dL (89.5 mol/L). Two vials, liquid reagents....
HDL Cholesterol, liquid....
For the quantitative determination of high density lipoprotein (HDL) in human serum....
Medicine Products: